A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
about
Oral acyclovir suppression and neurodevelopment after neonatal herpesEffect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesionsFamciclovir for treatment of herpesvirus infectionsXylotubercidin against herpes simplex virus type 2 in miceHIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selectionChemotherapeuticsValacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.New concepts in understanding genital herpes.Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover studyAcyclovir in first attacks of genital herpes and prevention of recurrencesEffect of recombinant interferon alpha 2 on clinical course of first episode genital herpes infection and subsequent recurrences.Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.Cutaneous herpes simplex infectionsLong-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study.Preventing neonatal herpes?Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study GroupGenital herpes: review of the epidemic and potential use of type-specific serologyImiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled studyChemotherapy for herpes simplex virus infectionsGeneral and family practice: genital herpes infectionAcyclovir in the prevention of duodenal ulcer recurrence.Challenges in genital herpes simplex virus management.Verrucous herpes of the scrotum in a human immunodeficiency virus-positive man: case report and review of the literature.Detailed analysis of mucosal herpes simplex virus-2 replication kinetics with and without antiviral therapy.Pediatric human immunodeficiency virus infection.Neonatal herpes prevention: a minor public health problem in some communities.Acyclovir prophylaxis for herpes simplex virus infection.Therapy of genital herpes with topically applied interferon.Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.Pharmacokinetics of acyclovir suspension in infants and children.Interferon in the prevention of genital herpes recurrence.A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes.In vitro activities of nucleoside analog antiviral agents against salmonellaeAntiviral therapy: current concepts and practicesContemporary antiviral drug regimens for the prevention and treatment of orolabial and anogenital herpes simplex virus infection in the normal host: Four approved indications and 13 off-label uses.'It's not about money, it's about my health': determinants of participation and adherence among women in an HIV-HSV2 prevention trial in Johannesburg, South AfricaGenital ulcers: their diagnosis and management.Expression of herpes simplex virus type 1 glycoproteins in interferon-treated human neuroblastoma cellsAntigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs.
P2860
Q24615077-C7EBEF3B-1E10-4A6E-9DDD-15C5DC6CE3A8Q24656625-85605F04-0A55-4756-9168-ED5A57AB7130Q28293932-9A3E6B8C-42AE-4338-BE12-E73385784AC4Q28362158-EF984847-A274-4DE5-8741-FD2B1220DDB7Q28478993-47BBC20A-1275-4CD4-ACBC-D49F6E4D95E6Q30047670-FAF5ED6E-E47F-4842-907F-C90D16CDD900Q30979930-85985D73-07EC-4AC8-AA38-CDABD88CB44AQ33582145-47FCDBAD-2014-42B0-AD73-5131DF468D1DQ33582991-98B323D3-1848-479E-91FF-F60463344C4CQ33583052-2DD82290-BD48-47AD-99FE-AB4C32C265F3Q33583092-0D7505B4-E647-4D7C-B7E0-B8B46E64A747Q33797142-5826625B-761D-4AD7-975C-2800B29B08A4Q33798406-3CEB4CEC-9E36-47BC-8A73-26ECB3CE6118Q33932423-D3C76BB1-C5E8-484B-B100-BBCB00BAB969Q33932537-6EB69388-7BD8-4029-A643-1635D933324CQ33932926-29978454-7523-4319-9DE8-80FB2855D83AQ33936572-277458AF-CD1E-43F8-B540-4C5F4AFA3B83Q33975387-FE1D8CA6-43DB-45ED-904C-305AF6ABBB29Q34144914-B5C3B3A9-A471-4B0C-BDDB-CA66A17DCED5Q34193041-CED79F3E-425B-4F1F-8DF2-53FC30FF6E54Q34194880-D26120E9-357B-47C7-B7D1-1161ED1DB5D3Q34391851-E7D3BEAE-5CA2-46F8-BB7D-FCCC752C1D9EQ34918258-ED4EFBEC-CCCB-4832-9059-3FBF9EF84EFAQ34995157-1F624028-C7E4-4B59-9093-3804F41AA5B6Q35328407-A02DAE12-5A94-401A-8D78-04BA35B56CE8Q35372072-19F68507-1C4B-4730-88B1-C30BEA70BBB4Q35528611-F77A5B04-7E05-415C-87C0-80361DD8802EQ35537506-E6CD48BD-0828-4BD1-B5B5-DF2CD8465389Q35540898-D5570A87-EA8D-4F43-9CFA-1FF3BDA3C5B9Q35541334-D011AC68-FCB8-4276-8ADA-3C041B7EA136Q35543240-106D41B8-D62A-4488-A743-D7EF3E53A54BQ35575396-9DB4A5B1-8EB4-4084-AF35-8B790A826F43Q35648857-DAB75549-7411-4636-8E20-31627FEC5630Q35807765-E185549C-04E4-428C-A921-9464A9DB8CB5Q36070394-529B56D2-F873-4CCD-9879-D702504BA123Q36170672-A920182A-445D-4EB3-833B-08DCC3F4E713Q36194047-23F90F86-4EC9-45B2-AF4D-13DE272224E2Q36413853-23B0F7E5-373B-4C01-959A-26980E06E9B3Q36784480-9353A871-4A4E-4B50-A651-C48A1150C182Q36829250-0530956B-36BC-4778-8F2B-14A7B9ABBCE4
P2860
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年学术文章
@wuu
1984年学术文章
@zh
1984年学术文章
@zh-cn
1984年学术文章
@zh-hans
1984年学术文章
@zh-my
1984年学术文章
@zh-sg
1984年學術文章
@yue
1984年學術文章
@zh-hant
name
A double-blind study of oral a ...... erpes simplex virus infection.
@en
A double-blind study of oral a ...... erpes simplex virus infection.
@nl
type
label
A double-blind study of oral a ...... erpes simplex virus infection.
@en
A double-blind study of oral a ...... erpes simplex virus infection.
@nl
prefLabel
A double-blind study of oral a ...... erpes simplex virus infection.
@en
A double-blind study of oral a ...... erpes simplex virus infection.
@nl
P2093
P1476
A double-blind study of oral a ...... erpes simplex virus infection.
@en
P2093
Benedetti J
Critchlow C
Douglas JM
Fahnlander A
Remington M
P304
P356
10.1056/NEJM198406143102402
P407
P577
1984-06-01T00:00:00Z